In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector

Human Gene Therapy

Volumn 7, Issue 13, 1996, Pages 1503-1514

  Arbuthnot, Patrick B ^a   Bralet, Marie Pierre ^a   Le Jossic, Catherine ^b   Dedieu, Jean François ^c   Perricaudet, Michel ^c   Bréchot, Christian ^a   Ferry, Nicolas ^a,b  

^a INSERM   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA GALACTOSIDASE; DNA; SOMATOMEDIN B; TRANSCRIPTION FACTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CANCER; LIVER PARENCHYMA; MARKER GENE; MOUSE; NONHUMAN; NUDE MOUSE; RAT;

EID: 0029759957     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.13-1503     Document Type: Article

References (39)

1. ALBRECHTSEN, R., WEWER, U.M., and THORGEIRSSON, S.S. (1988). De novo deposition of laminin positive basement membrane in vitro by normal hepatocytes and during hepatocarcinogenesis. Hepatology 8, 538-546.
2. ARBUTHNOT, P., BRALET, M.P., THOMASSIN, H., DANAN, J.L., BRECHOT, C., and FERRY, N. (1995). Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences. Hepatology 22, 1788-1796.
3. BAO, J.J., ZHANG, W.W., and KUO, M.T. (1996). Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas. Hum. Gene Ther. 7, 355-365.
4. BECK, C., CAYEUX, S., LUPTON, S.D., DÖRKEN, B., and BLANKENSTEIN, T. (1995). The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells. Hum. Gene Ther. 6, 1525-1530.
5. BERNIER, D., THOMASSIN, H., ALLARD, D., GUERTIN, M., HAMEL, D., BLAQUIERE, M., BEAUCHEMIN, M., LARUE, H., ESTABLEPUIG, M., and BELANGER, L. (1993). Functional analysis of developmentally regulated chromatin-hypersensitive domains carrying the alpha 1-fetoprotein gene promoter and the albumin/alpha1-fetoprotein intergenic enhancer. Mol. Cell. Biol. 13, 1619-1633.
6. BOVIATSIS, E.J., CHASE, M., WEI, M.X., TAMIYA, T., HURFORD, R.K., KOWALL, N.W., TEPPER, R.I., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
7. CARIANI, E., SEWIN, D., LASSERRE, C., FRANCO, D., BINOUX, M., and BRECHOT, C. (1990). Expression of insulin-like growth factor II (IGF II) in human primary liver cancer: mRNA and protein analysis. J. Hepatol. 11, 226-231.
8. CARUSO, M., PANIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J.L., and KLATZMANN, D. (1993). Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA 90, 7024-7028.
9. CHEN, S.H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L.C. (1994). Gene therapy for brain tumors - Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
10. CHEN, S.H., CHEN, X.H.L., WANG, T.B., KOSAI, K.I., FINEGOLD, M.J., RICH, S.S., and WOO, S.L.C. (1995). Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92, 2577-2581.
11. CULVER, K.W., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-produced cells for treatment of experimental brain tumor. Science 256, 1550-1552.
12. EMERSON, J.A., VACHER, J., CIRILLO, L.A., TILGHMAN, S.M., and TYNER, A.L. (1992). The Zonal Expression of alpha-fetoprotein transgenes in the livers of adult mice. Devel. Dynam. 195, 55-66.
13. FERRY, N., DUPLESSIS, O., HOUSSIN, D., DANOS, O., and HEARD, J.M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381.
14. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The bystander effect - tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
15. HARATAKE, J., HISAOKA, M., YAMAMOTO, O., and HORIE, A. (1992). An ultrastructural comparison of sinusoids in hepatocellular carcinoma, adenomatous hyperplasia and fetal liver. Arch. Pathol. Lab. Med. 116, 67-70.
16. HAYASHI, Y., DEPAOLI, A.M., BURANT, C.F., and REFETOFF, S. (1994). Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J. Biol. Chem. 269, 23872-23875.
17. IDO, A., NAKATA, K., KATO, Y., NAKAO, K., MURATA, K., FUJITA, M., ISHII, N., TAMAOKI, T., SHIKU, H., and NAGATAKI, S. (1995). Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res. 55, 3105-3109.
18. KANEKO, S., HALLENBECK, P., KOTANI, T., NAKABAYASHI, H., MCGARRITY, G., TAMAOKI, T., ANDERSON, W.F., and CHIANG, Y.L. (1995). Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer specific gene expression. Cancer Res. 55, 5283-5287.
19. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.A., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M., and WOO, S.L.C. (1993). In vivo gene therapy of hemophilia-B-sustained partial correction in factor-IX-deficient dogs. Science 262, 117-119.
20. KIMURA, O., YAMAGUCHI, Y., GUNNING, K.B., TEETER, L.D., HUSAIN, F. and KUO, M.T. (1994). Retroviral delivery of DNA into the livers of transgenic mice bearing premalignant and malignant hepatocellular carcinomas. Hum. Gene Ther. 5, 845-852.
21. KURIYAMA, S., NAKATANI, T., MASUI, K., SAKAMOTO, T., TOMINAGA, K., YOSHIKAWA, M., FUKUI, H., IKENADA, K., and TSUJII, T. (1995). Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology 22, 1838-1846.
22. LEDLEY, F.D. (1993). Hepatic gene therapy - Present and future. Hepatology 18, 1263-1273.
23. LI, Q.T., KAY, M.A., FINEGOLD, M., STRATFORD-PERRICAUDET, L.D., and WOO, S.L.C. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
24. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
25. PEREZCRUET, M.J., TRASK, T.W., CHEN, S.H., GOODMAN, J.C., WOO, S.L.C., GROSSMAN R.G., and SHINE, H.D. (1994). Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res. 39, 506-511.
26. POLLIARD, A., BAKKALI, L., POIRET, M., FOIRET, D., and DANAN, J.L. (1990). Regulation of the rat alpha-fetoprotein gene expression in liver: both the promoter region and the enhancer element are liver specific and negatively modulated by dexamethasone. J. Biol. Chem. 265, 2137-2141.
27. QIAN, C., BILBAO, R.. BRUNA, O., and PRIETO, J. (1995). Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 22, 118-123.
28. RESCAN, P.Y., CLÉMENT, B., YAMADA, Y., SEGUI-REAL, B., BAFFET, G., GUGUEN-GUILLOUZO, C., and GUILLOUZO, A. (1990). Differential expression of laminin chains and receptor (LBP 32) in fetal and neoplastic hepatocytes compared to normal adult hepatocytes in vivo and in culture. Am. J. Pathol. 137, 701-709.
29. SCHAFFNER, F., and POPPER, H. (1963). Capillarization of hepatic sinusoids in man. Gastroenterology 44, 239-242.
30. SCOAZEC, J.Y., FLEJOU, J.F., D'ERRICO, A., COUVELARD, A., ZOZYRAKI, R., FIORENTINO, M., GRIGIONI, W.F., and FELDMANN, G. (1995). Focal nodular hyperplasia of the liver: Composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules. Hum. Pathol. 26, 1114-1125.
31. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.
32. SUSSENBACH, J.S., STEENBERGH, P.H., and HOLTHUIZEN, P. (1992). Structure and expression of the human insulin-like growth factor genes. Growth Regul. 2, 1-9.
33. VOLPES, R., VAN DER OORD, J.J., and DESMET, V.J. (1993). Integrins as differential cell lineage markers of primary liver tumors. Am. J. Pathol. 142, 1483-1492.
34. WEN, P., CRAWFORD, N., and LOCKER, J. (1993). A promoter-linked coupling region required for stimulation of alpha-fetoprotein transcription by distant enhancers. Nucleic Acids Res. 21, 1911-1918.
35. WICKHAM, T.J., MATHIAS, P., CHERESH, D.A., and NEMEROW, G.R. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
36. WICKHAM, T.J., FILARDO, E.J., CHERESH, D.A., and NEMEROW, G.R. (1994). Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127, 257-264.
37. WILLS, K.N., HUANG, W.H., HARRIS, M.P., MACHEMER, T., MANEVAL, D.C., and GREGORY, R.J. (1995). Gene therapy for hepatocellular carcinoma: Chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther. 2, 191-197.
38. YANG, Y.P., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
39. ZHANG, D.E., RABEK, J.P., HSIEH, C.C., TORRES-RAMOS, C., and PAPCONSTANTINOU, J. (1992). Functional analysis of the mouse alpha-fetoprotein enhancers and their subfragments in primary mouse hepatocyte cultures. J. Biol. Chem. 267, 10676-10682.